Global CD30 (TNFRSF8) Protein Production, Demand and Key Producers, 2022-2028
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication.
This report studies the global CD30 (TNFRSF8) Protein production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD30 (TNFRSF8) Protein, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD30 (TNFRSF8) Protein that contribute to its increasing demand across many markets.
The global CD30 (TNFRSF8) Protein market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CD30 (TNFRSF8) Protein total production and demand, 2017-2028, (K Units)
Global CD30 (TNFRSF8) Protein total production value, 2017-2028, (USD Million)
Global CD30 (TNFRSF8) Protein production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CD30 (TNFRSF8) Protein consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: CD30 (TNFRSF8) Protein domestic production, consumption, key domestic manufacturers and share
Global CD30 (TNFRSF8) Protein production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global CD30 (TNFRSF8) Protein production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CD30 (TNFRSF8) Protein production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global CD30 (TNFRSF8) Protein market based on the following parameters – headquarters, production locations, products portfolio, CD30 (TNFRSF8) Protein revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD30 (TNFRSF8) Protein market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CD30 (TNFRSF8) Protein Market, By Region:
1. How big is the global CD30 (TNFRSF8) Protein market?
2. What is the demand of the global CD30 (TNFRSF8) Protein market?
3. What is the year over year growth of the global CD30 (TNFRSF8) Protein market?
4. What is the production and production value of the global CD30 (TNFRSF8) Protein market?
5. Who are the key producers in the global CD30 (TNFRSF8) Protein market?
6. What are the growth factors driving the market demand?
This report studies the global CD30 (TNFRSF8) Protein production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for CD30 (TNFRSF8) Protein, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD30 (TNFRSF8) Protein that contribute to its increasing demand across many markets.
The global CD30 (TNFRSF8) Protein market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global CD30 (TNFRSF8) Protein total production and demand, 2017-2028, (K Units)
Global CD30 (TNFRSF8) Protein total production value, 2017-2028, (USD Million)
Global CD30 (TNFRSF8) Protein production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CD30 (TNFRSF8) Protein consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: CD30 (TNFRSF8) Protein domestic production, consumption, key domestic manufacturers and share
Global CD30 (TNFRSF8) Protein production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global CD30 (TNFRSF8) Protein production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global CD30 (TNFRSF8) Protein production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global CD30 (TNFRSF8) Protein market based on the following parameters – headquarters, production locations, products portfolio, CD30 (TNFRSF8) Protein revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CD30 (TNFRSF8) Protein market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global CD30 (TNFRSF8) Protein Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Purity : Greater Than 85%
- Purity : Greater Than 90%
- Purity : Greater Than 95%
- Purity : Greater Than 97%
- Other
- SDS-PAGE
- ELISA
- Other
- Sino Biological, Inc.
- Bio-Techne
- Elabscience Biotechnology Inc.
- Abbexa
- MyBiosource, Inc.
- OriGene Technologies, Inc.
- Prospec-Tany Technogene Ltd.
- KACTUS
- G&P Biosciences
- ACROBiosystems
- Assay Genie
- ZellBio GmbH
1. How big is the global CD30 (TNFRSF8) Protein market?
2. What is the demand of the global CD30 (TNFRSF8) Protein market?
3. What is the year over year growth of the global CD30 (TNFRSF8) Protein market?
4. What is the production and production value of the global CD30 (TNFRSF8) Protein market?
5. Who are the key producers in the global CD30 (TNFRSF8) Protein market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 CD30 (TNFRSF8) Protein Introduction
1.2 World CD30 (TNFRSF8) Protein Supply & Forecast
1.2.1 World CD30 (TNFRSF8) Protein Production Value (2017 & 2021 & 2028)
1.2.2 World CD30 (TNFRSF8) Protein Production (2017-2028)
1.2.3 World CD30 (TNFRSF8) Protein Pricing Trends (2017-2028)
1.3 World CD30 (TNFRSF8) Protein Production by Region
1.3.1 World CD30 (TNFRSF8) Protein Production Value by Region (2017-2028)
1.3.2 World CD30 (TNFRSF8) Protein Production by Region (2017-2028)
1.3.3 World CD30 (TNFRSF8) Protein Average Price by Region (2017-2028)
1.3.4 North America CD30 (TNFRSF8) Protein Production (2017-2028)
1.3.5 Europe CD30 (TNFRSF8) Protein Production (2017-2028)
1.3.6 China CD30 (TNFRSF8) Protein Production (2017-2028)
1.3.7 Japan CD30 (TNFRSF8) Protein Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD30 (TNFRSF8) Protein Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD30 (TNFRSF8) Protein Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD30 (TNFRSF8) Protein Demand (2017-2028)
2.2 World CD30 (TNFRSF8) Protein Consumption by Region
2.2.1 World CD30 (TNFRSF8) Protein Consumption by Region (2017-2022)
2.2.2 World CD30 (TNFRSF8) Protein Consumption Forecast by Region (2023-2028)
2.3 United States CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.4 China CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.5 Europe CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.6 Japan CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.7 South Korea CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.8 ASEAN CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.9 India CD30 (TNFRSF8) Protein Consumption (2017-2028)
3 WORLD CD30 (TNFRSF8) PROTEIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD30 (TNFRSF8) Protein Production Value by Manufacturer (2017-2022)
3.2 World CD30 (TNFRSF8) Protein Production by Manufacturer (2017-2022)
3.3 World CD30 (TNFRSF8) Protein Average Price by Manufacturer (2017-2022)
3.4 CD30 (TNFRSF8) Protein Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD30 (TNFRSF8) Protein Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD30 (TNFRSF8) Protein in 2021
3.5.3 Global Concentration Ratios (CR8) for CD30 (TNFRSF8) Protein in 2021
3.6 CD30 (TNFRSF8) Protein Market: Overall Company Footprint Analysis
3.6.1 CD30 (TNFRSF8) Protein Market: Region Footprint
3.6.2 CD30 (TNFRSF8) Protein Market: Company Product Type Footprint
3.6.3 CD30 (TNFRSF8) Protein Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD30 (TNFRSF8) Protein Production Value Comparison
4.1.1 United States VS China: CD30 (TNFRSF8) Protein Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: CD30 (TNFRSF8) Protein Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: CD30 (TNFRSF8) Protein Production Comparison
4.2.1 United States VS China: CD30 (TNFRSF8) Protein Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: CD30 (TNFRSF8) Protein Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: CD30 (TNFRSF8) Protein Consumption Comparison
4.3.1 United States VS China: CD30 (TNFRSF8) Protein Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: CD30 (TNFRSF8) Protein Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States CD30 (TNFRSF8) Protein Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of CD30 (TNFRSF8) Protein in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022)
4.5 China CD30 (TNFRSF8) Protein Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of CD30 (TNFRSF8) Protein in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World CD30 (TNFRSF8) Protein Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of CD30 (TNFRSF8) Protein in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World CD30 (TNFRSF8) Protein Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Purity : Greater Than 85%
5.2.2 Purity : Greater Than 90%
5.2.3 Purity : Greater Than 95%
5.2.4 Purity : Greater Than 97%
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World CD30 (TNFRSF8) Protein Production by Type (2017-2028)
5.3.2 World CD30 (TNFRSF8) Protein Production Value by Type (2017-2028)
5.3.3 World CD30 (TNFRSF8) Protein Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD30 (TNFRSF8) Protein Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 SDS-PAGE
6.2.2 ELISA
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World CD30 (TNFRSF8) Protein Production by Application (2017-2028)
6.3.2 World CD30 (TNFRSF8) Protein Production Value by Application (2017-2028)
6.3.3 World CD30 (TNFRSF8) Protein Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. CD30 (TNFRSF8) Protein Product and Services
7.1.4 Sino Biological, Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 Bio-Techne
7.2.1 Bio-Techne Details
7.2.2 Bio-Techne Major Business
7.2.3 Bio-Techne CD30 (TNFRSF8) Protein Product and Services
7.2.4 Bio-Techne CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bio-Techne Recent Developments/Updates
7.2.6 Bio-Techne Competitive Strengths & Weaknesses
7.3 Elabscience Biotechnology Inc.
7.3.1 Elabscience Biotechnology Inc. Details
7.3.2 Elabscience Biotechnology Inc. Major Business
7.3.3 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product and Services
7.3.4 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.3.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.4 Abbexa
7.4.1 Abbexa Details
7.4.2 Abbexa Major Business
7.4.3 Abbexa CD30 (TNFRSF8) Protein Product and Services
7.4.4 Abbexa CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Abbexa Recent Developments/Updates
7.4.6 Abbexa Competitive Strengths & Weaknesses
7.5 MyBiosource, Inc.
7.5.1 MyBiosource, Inc. Details
7.5.2 MyBiosource, Inc. Major Business
7.5.3 MyBiosource, Inc. CD30 (TNFRSF8) Protein Product and Services
7.5.4 MyBiosource, Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 MyBiosource, Inc. Recent Developments/Updates
7.5.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
7.6 OriGene Technologies, Inc.
7.6.1 OriGene Technologies, Inc. Details
7.6.2 OriGene Technologies, Inc. Major Business
7.6.3 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product and Services
7.6.4 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 OriGene Technologies, Inc. Recent Developments/Updates
7.6.6 OriGene Technologies, Inc. Competitive Strengths & Weaknesses
7.7 Prospec-Tany Technogene Ltd.
7.7.1 Prospec-Tany Technogene Ltd. Details
7.7.2 Prospec-Tany Technogene Ltd. Major Business
7.7.3 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product and Services
7.7.4 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Prospec-Tany Technogene Ltd. Recent Developments/Updates
7.7.6 Prospec-Tany Technogene Ltd. Competitive Strengths & Weaknesses
7.8 KACTUS
7.8.1 KACTUS Details
7.8.2 KACTUS Major Business
7.8.3 KACTUS CD30 (TNFRSF8) Protein Product and Services
7.8.4 KACTUS CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 KACTUS Recent Developments/Updates
7.8.6 KACTUS Competitive Strengths & Weaknesses
7.9 G&P Biosciences
7.9.1 G&P Biosciences Details
7.9.2 G&P Biosciences Major Business
7.9.3 G&P Biosciences CD30 (TNFRSF8) Protein Product and Services
7.9.4 G&P Biosciences CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 G&P Biosciences Recent Developments/Updates
7.9.6 G&P Biosciences Competitive Strengths & Weaknesses
7.10 ACROBiosystems
7.10.1 ACROBiosystems Details
7.10.2 ACROBiosystems Major Business
7.10.3 ACROBiosystems CD30 (TNFRSF8) Protein Product and Services
7.10.4 ACROBiosystems CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 ACROBiosystems Recent Developments/Updates
7.10.6 ACROBiosystems Competitive Strengths & Weaknesses
7.11 Assay Genie
7.11.1 Assay Genie Details
7.11.2 Assay Genie Major Business
7.11.3 Assay Genie CD30 (TNFRSF8) Protein Product and Services
7.11.4 Assay Genie CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Assay Genie Recent Developments/Updates
7.11.6 Assay Genie Competitive Strengths & Weaknesses
7.12 ZellBio GmbH
7.12.1 ZellBio GmbH Details
7.12.2 ZellBio GmbH Major Business
7.12.3 ZellBio GmbH CD30 (TNFRSF8) Protein Product and Services
7.12.4 ZellBio GmbH CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 ZellBio GmbH Recent Developments/Updates
7.12.6 ZellBio GmbH Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of CD30 (TNFRSF8) Protein and Key Manufacturers
8.2 CD30 (TNFRSF8) Protein Manufacturing Costs
8.3 CD30 (TNFRSF8) Protein Production Process
8.4 CD30 (TNFRSF8) Protein Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for CD30 (TNFRSF8) Protein Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 CD30 (TNFRSF8) Protein Typical Distributors
9.3 CD30 (TNFRSF8) Protein Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 CD30 (TNFRSF8) Protein Introduction
1.2 World CD30 (TNFRSF8) Protein Supply & Forecast
1.2.1 World CD30 (TNFRSF8) Protein Production Value (2017 & 2021 & 2028)
1.2.2 World CD30 (TNFRSF8) Protein Production (2017-2028)
1.2.3 World CD30 (TNFRSF8) Protein Pricing Trends (2017-2028)
1.3 World CD30 (TNFRSF8) Protein Production by Region
1.3.1 World CD30 (TNFRSF8) Protein Production Value by Region (2017-2028)
1.3.2 World CD30 (TNFRSF8) Protein Production by Region (2017-2028)
1.3.3 World CD30 (TNFRSF8) Protein Average Price by Region (2017-2028)
1.3.4 North America CD30 (TNFRSF8) Protein Production (2017-2028)
1.3.5 Europe CD30 (TNFRSF8) Protein Production (2017-2028)
1.3.6 China CD30 (TNFRSF8) Protein Production (2017-2028)
1.3.7 Japan CD30 (TNFRSF8) Protein Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 CD30 (TNFRSF8) Protein Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CD30 (TNFRSF8) Protein Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World CD30 (TNFRSF8) Protein Demand (2017-2028)
2.2 World CD30 (TNFRSF8) Protein Consumption by Region
2.2.1 World CD30 (TNFRSF8) Protein Consumption by Region (2017-2022)
2.2.2 World CD30 (TNFRSF8) Protein Consumption Forecast by Region (2023-2028)
2.3 United States CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.4 China CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.5 Europe CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.6 Japan CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.7 South Korea CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.8 ASEAN CD30 (TNFRSF8) Protein Consumption (2017-2028)
2.9 India CD30 (TNFRSF8) Protein Consumption (2017-2028)
3 WORLD CD30 (TNFRSF8) PROTEIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World CD30 (TNFRSF8) Protein Production Value by Manufacturer (2017-2022)
3.2 World CD30 (TNFRSF8) Protein Production by Manufacturer (2017-2022)
3.3 World CD30 (TNFRSF8) Protein Average Price by Manufacturer (2017-2022)
3.4 CD30 (TNFRSF8) Protein Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global CD30 (TNFRSF8) Protein Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for CD30 (TNFRSF8) Protein in 2021
3.5.3 Global Concentration Ratios (CR8) for CD30 (TNFRSF8) Protein in 2021
3.6 CD30 (TNFRSF8) Protein Market: Overall Company Footprint Analysis
3.6.1 CD30 (TNFRSF8) Protein Market: Region Footprint
3.6.2 CD30 (TNFRSF8) Protein Market: Company Product Type Footprint
3.6.3 CD30 (TNFRSF8) Protein Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: CD30 (TNFRSF8) Protein Production Value Comparison
4.1.1 United States VS China: CD30 (TNFRSF8) Protein Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: CD30 (TNFRSF8) Protein Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: CD30 (TNFRSF8) Protein Production Comparison
4.2.1 United States VS China: CD30 (TNFRSF8) Protein Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: CD30 (TNFRSF8) Protein Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: CD30 (TNFRSF8) Protein Consumption Comparison
4.3.1 United States VS China: CD30 (TNFRSF8) Protein Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: CD30 (TNFRSF8) Protein Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States CD30 (TNFRSF8) Protein Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of CD30 (TNFRSF8) Protein in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022)
4.5 China CD30 (TNFRSF8) Protein Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of CD30 (TNFRSF8) Protein in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World CD30 (TNFRSF8) Protein Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of CD30 (TNFRSF8) Protein in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World CD30 (TNFRSF8) Protein Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Purity : Greater Than 85%
5.2.2 Purity : Greater Than 90%
5.2.3 Purity : Greater Than 95%
5.2.4 Purity : Greater Than 97%
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World CD30 (TNFRSF8) Protein Production by Type (2017-2028)
5.3.2 World CD30 (TNFRSF8) Protein Production Value by Type (2017-2028)
5.3.3 World CD30 (TNFRSF8) Protein Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CD30 (TNFRSF8) Protein Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 SDS-PAGE
6.2.2 ELISA
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World CD30 (TNFRSF8) Protein Production by Application (2017-2028)
6.3.2 World CD30 (TNFRSF8) Protein Production Value by Application (2017-2028)
6.3.3 World CD30 (TNFRSF8) Protein Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Sino Biological, Inc.
7.1.1 Sino Biological, Inc. Details
7.1.2 Sino Biological, Inc. Major Business
7.1.3 Sino Biological, Inc. CD30 (TNFRSF8) Protein Product and Services
7.1.4 Sino Biological, Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Sino Biological, Inc. Recent Developments/Updates
7.1.6 Sino Biological, Inc. Competitive Strengths & Weaknesses
7.2 Bio-Techne
7.2.1 Bio-Techne Details
7.2.2 Bio-Techne Major Business
7.2.3 Bio-Techne CD30 (TNFRSF8) Protein Product and Services
7.2.4 Bio-Techne CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Bio-Techne Recent Developments/Updates
7.2.6 Bio-Techne Competitive Strengths & Weaknesses
7.3 Elabscience Biotechnology Inc.
7.3.1 Elabscience Biotechnology Inc. Details
7.3.2 Elabscience Biotechnology Inc. Major Business
7.3.3 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product and Services
7.3.4 Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Elabscience Biotechnology Inc. Recent Developments/Updates
7.3.6 Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
7.4 Abbexa
7.4.1 Abbexa Details
7.4.2 Abbexa Major Business
7.4.3 Abbexa CD30 (TNFRSF8) Protein Product and Services
7.4.4 Abbexa CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Abbexa Recent Developments/Updates
7.4.6 Abbexa Competitive Strengths & Weaknesses
7.5 MyBiosource, Inc.
7.5.1 MyBiosource, Inc. Details
7.5.2 MyBiosource, Inc. Major Business
7.5.3 MyBiosource, Inc. CD30 (TNFRSF8) Protein Product and Services
7.5.4 MyBiosource, Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 MyBiosource, Inc. Recent Developments/Updates
7.5.6 MyBiosource, Inc. Competitive Strengths & Weaknesses
7.6 OriGene Technologies, Inc.
7.6.1 OriGene Technologies, Inc. Details
7.6.2 OriGene Technologies, Inc. Major Business
7.6.3 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product and Services
7.6.4 OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 OriGene Technologies, Inc. Recent Developments/Updates
7.6.6 OriGene Technologies, Inc. Competitive Strengths & Weaknesses
7.7 Prospec-Tany Technogene Ltd.
7.7.1 Prospec-Tany Technogene Ltd. Details
7.7.2 Prospec-Tany Technogene Ltd. Major Business
7.7.3 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product and Services
7.7.4 Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Prospec-Tany Technogene Ltd. Recent Developments/Updates
7.7.6 Prospec-Tany Technogene Ltd. Competitive Strengths & Weaknesses
7.8 KACTUS
7.8.1 KACTUS Details
7.8.2 KACTUS Major Business
7.8.3 KACTUS CD30 (TNFRSF8) Protein Product and Services
7.8.4 KACTUS CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 KACTUS Recent Developments/Updates
7.8.6 KACTUS Competitive Strengths & Weaknesses
7.9 G&P Biosciences
7.9.1 G&P Biosciences Details
7.9.2 G&P Biosciences Major Business
7.9.3 G&P Biosciences CD30 (TNFRSF8) Protein Product and Services
7.9.4 G&P Biosciences CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 G&P Biosciences Recent Developments/Updates
7.9.6 G&P Biosciences Competitive Strengths & Weaknesses
7.10 ACROBiosystems
7.10.1 ACROBiosystems Details
7.10.2 ACROBiosystems Major Business
7.10.3 ACROBiosystems CD30 (TNFRSF8) Protein Product and Services
7.10.4 ACROBiosystems CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 ACROBiosystems Recent Developments/Updates
7.10.6 ACROBiosystems Competitive Strengths & Weaknesses
7.11 Assay Genie
7.11.1 Assay Genie Details
7.11.2 Assay Genie Major Business
7.11.3 Assay Genie CD30 (TNFRSF8) Protein Product and Services
7.11.4 Assay Genie CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Assay Genie Recent Developments/Updates
7.11.6 Assay Genie Competitive Strengths & Weaknesses
7.12 ZellBio GmbH
7.12.1 ZellBio GmbH Details
7.12.2 ZellBio GmbH Major Business
7.12.3 ZellBio GmbH CD30 (TNFRSF8) Protein Product and Services
7.12.4 ZellBio GmbH CD30 (TNFRSF8) Protein Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 ZellBio GmbH Recent Developments/Updates
7.12.6 ZellBio GmbH Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of CD30 (TNFRSF8) Protein and Key Manufacturers
8.2 CD30 (TNFRSF8) Protein Manufacturing Costs
8.3 CD30 (TNFRSF8) Protein Production Process
8.4 CD30 (TNFRSF8) Protein Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for CD30 (TNFRSF8) Protein Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 CD30 (TNFRSF8) Protein Typical Distributors
9.3 CD30 (TNFRSF8) Protein Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World CD30 (TNFRSF8) Protein Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CD30 (TNFRSF8) Protein Production Value by Region (2017-2022) & (USD Million)
Table 3. World CD30 (TNFRSF8) Protein Production Value by Region (2023-2028) & (USD Million)
Table 4. World CD30 (TNFRSF8) Protein Production Value Market Share by Region (2017-2022)
Table 5. World CD30 (TNFRSF8) Protein Production Value Market Share by Region (2023-2028)
Table 6. World CD30 (TNFRSF8) Protein Production by Region (2017-2022) & (K Units)
Table 7. World CD30 (TNFRSF8) Protein Production by Region (2023-2028) & (K Units)
Table 8. World CD30 (TNFRSF8) Protein Production Market Share by Region (2017-2022)
Table 9. World CD30 (TNFRSF8) Protein Production Market Share by Region (2023-2028)
Table 10. World CD30 (TNFRSF8) Protein Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World CD30 (TNFRSF8) Protein Average Price by Region (2023-2028) & (US$/Unit)
Table 12. CD30 (TNFRSF8) Protein Major Market Trends
Table 13. World CD30 (TNFRSF8) Protein Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World CD30 (TNFRSF8) Protein Consumption by Region (2017-2022) & (K Units)
Table 15. World CD30 (TNFRSF8) Protein Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World CD30 (TNFRSF8) Protein Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key CD30 (TNFRSF8) Protein Producers in 2021
Table 18. World CD30 (TNFRSF8) Protein Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key CD30 (TNFRSF8) Protein Producers in 2021
Table 20. World CD30 (TNFRSF8) Protein Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global CD30 (TNFRSF8) Protein Company Evaluation Quadrant
Table 22. World CD30 (TNFRSF8) Protein Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and CD30 (TNFRSF8) Protein Production Site of Key Manufacturer
Table 24. CD30 (TNFRSF8) Protein Market: Company Product Type Footprint
Table 25. CD30 (TNFRSF8) Protein Market: Company Product Application Footprint
Table 26. CD30 (TNFRSF8) Protein Competitive Factors
Table 27. CD30 (TNFRSF8) Protein New Entrant and Capacity Expansion Plans
Table 28. CD30 (TNFRSF8) Protein Mergers & Acquisitions Activity
Table 29. United States VS China CD30 (TNFRSF8) Protein Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China CD30 (TNFRSF8) Protein Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China CD30 (TNFRSF8) Protein Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of CD30 (TNFRSF8) Protein in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States CD30 (TNFRSF8) Protein Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States CD30 (TNFRSF8) Protein Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of CD30 (TNFRSF8) Protein in China, Company Headquarters and Production Place (Province, Country)
Table 38. China CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China CD30 (TNFRSF8) Protein Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China CD30 (TNFRSF8) Protein Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of CD30 (TNFRSF8) Protein in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World CD30 (TNFRSF8) Protein Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World CD30 (TNFRSF8) Protein Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World CD30 (TNFRSF8) Protein Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World CD30 (TNFRSF8) Protein Production by Type (2017-2022) & (K Units)
Table 49. World CD30 (TNFRSF8) Protein Production by Type (2023-2028) & (K Units)
Table 50. World CD30 (TNFRSF8) Protein Production Value by Type (2017-2022) & (USD Million)
Table 51. World CD30 (TNFRSF8) Protein Production Value by Type (2023-2028) & (USD Million)
Table 52. World CD30 (TNFRSF8) Protein Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World CD30 (TNFRSF8) Protein Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World CD30 (TNFRSF8) Protein Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World CD30 (TNFRSF8) Protein Production by Application (2017-2022) & (K Units)
Table 56. World CD30 (TNFRSF8) Protein Production by Application (2023-2028) & (K Units)
Table 57. World CD30 (TNFRSF8) Protein Production Value by Application (2017-2022) & (USD Million)
Table 58. World CD30 (TNFRSF8) Protein Production Value by Application (2023-2028) & (USD Million)
Table 59. World CD30 (TNFRSF8) Protein Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World CD30 (TNFRSF8) Protein Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. CD30 (TNFRSF8) Protein Product and Services
Table 64. Sino Biological, Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Techne Major Business
Table 69. Bio-Techne CD30 (TNFRSF8) Protein Product and Services
Table 70. Bio-Techne CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bio-Techne Recent Developments/Updates
Table 72. Bio-Techne Competitive Strengths & Weaknesses
Table 73. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Elabscience Biotechnology Inc. Major Business
Table 75. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product and Services
Table 76. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 78. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 79. Abbexa Basic Information, Manufacturing Base and Competitors
Table 80. Abbexa Major Business
Table 81. Abbexa CD30 (TNFRSF8) Protein Product and Services
Table 82. Abbexa CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Abbexa Recent Developments/Updates
Table 84. Abbexa Competitive Strengths & Weaknesses
Table 85. MyBiosource, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. MyBiosource, Inc. Major Business
Table 87. MyBiosource, Inc. CD30 (TNFRSF8) Protein Product and Services
Table 88. MyBiosource, Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. MyBiosource, Inc. Recent Developments/Updates
Table 90. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 91. OriGene Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. OriGene Technologies, Inc. Major Business
Table 93. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product and Services
Table 94. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. OriGene Technologies, Inc. Recent Developments/Updates
Table 96. OriGene Technologies, Inc. Competitive Strengths & Weaknesses
Table 97. Prospec-Tany Technogene Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Prospec-Tany Technogene Ltd. Major Business
Table 99. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product and Services
Table 100. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Prospec-Tany Technogene Ltd. Recent Developments/Updates
Table 102. Prospec-Tany Technogene Ltd. Competitive Strengths & Weaknesses
Table 103. KACTUS Basic Information, Manufacturing Base and Competitors
Table 104. KACTUS Major Business
Table 105. KACTUS CD30 (TNFRSF8) Protein Product and Services
Table 106. KACTUS CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. KACTUS Recent Developments/Updates
Table 108. KACTUS Competitive Strengths & Weaknesses
Table 109. G&P Biosciences Basic Information, Manufacturing Base and Competitors
Table 110. G&P Biosciences Major Business
Table 111. G&P Biosciences CD30 (TNFRSF8) Protein Product and Services
Table 112. G&P Biosciences CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. G&P Biosciences Recent Developments/Updates
Table 114. G&P Biosciences Competitive Strengths & Weaknesses
Table 115. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 116. ACROBiosystems Major Business
Table 117. ACROBiosystems CD30 (TNFRSF8) Protein Product and Services
Table 118. ACROBiosystems CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. ACROBiosystems Recent Developments/Updates
Table 120. ACROBiosystems Competitive Strengths & Weaknesses
Table 121. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 122. Assay Genie Major Business
Table 123. Assay Genie CD30 (TNFRSF8) Protein Product and Services
Table 124. Assay Genie CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Assay Genie Recent Developments/Updates
Table 126. ZellBio GmbH Basic Information, Manufacturing Base and Competitors
Table 127. ZellBio GmbH Major Business
Table 128. ZellBio GmbH CD30 (TNFRSF8) Protein Product and Services
Table 129. ZellBio GmbH CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. CD30 (TNFRSF8) Protein Raw Material
Table 131. Key Manufacturers of CD30 (TNFRSF8) Protein Raw Materials
Table 132. CD30 (TNFRSF8) Protein Typical Distributors
Table 133. CD30 (TNFRSF8) Protein Typical Customers
Table 1. World CD30 (TNFRSF8) Protein Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World CD30 (TNFRSF8) Protein Production Value by Region (2017-2022) & (USD Million)
Table 3. World CD30 (TNFRSF8) Protein Production Value by Region (2023-2028) & (USD Million)
Table 4. World CD30 (TNFRSF8) Protein Production Value Market Share by Region (2017-2022)
Table 5. World CD30 (TNFRSF8) Protein Production Value Market Share by Region (2023-2028)
Table 6. World CD30 (TNFRSF8) Protein Production by Region (2017-2022) & (K Units)
Table 7. World CD30 (TNFRSF8) Protein Production by Region (2023-2028) & (K Units)
Table 8. World CD30 (TNFRSF8) Protein Production Market Share by Region (2017-2022)
Table 9. World CD30 (TNFRSF8) Protein Production Market Share by Region (2023-2028)
Table 10. World CD30 (TNFRSF8) Protein Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World CD30 (TNFRSF8) Protein Average Price by Region (2023-2028) & (US$/Unit)
Table 12. CD30 (TNFRSF8) Protein Major Market Trends
Table 13. World CD30 (TNFRSF8) Protein Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World CD30 (TNFRSF8) Protein Consumption by Region (2017-2022) & (K Units)
Table 15. World CD30 (TNFRSF8) Protein Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World CD30 (TNFRSF8) Protein Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key CD30 (TNFRSF8) Protein Producers in 2021
Table 18. World CD30 (TNFRSF8) Protein Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key CD30 (TNFRSF8) Protein Producers in 2021
Table 20. World CD30 (TNFRSF8) Protein Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global CD30 (TNFRSF8) Protein Company Evaluation Quadrant
Table 22. World CD30 (TNFRSF8) Protein Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and CD30 (TNFRSF8) Protein Production Site of Key Manufacturer
Table 24. CD30 (TNFRSF8) Protein Market: Company Product Type Footprint
Table 25. CD30 (TNFRSF8) Protein Market: Company Product Application Footprint
Table 26. CD30 (TNFRSF8) Protein Competitive Factors
Table 27. CD30 (TNFRSF8) Protein New Entrant and Capacity Expansion Plans
Table 28. CD30 (TNFRSF8) Protein Mergers & Acquisitions Activity
Table 29. United States VS China CD30 (TNFRSF8) Protein Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China CD30 (TNFRSF8) Protein Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China CD30 (TNFRSF8) Protein Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of CD30 (TNFRSF8) Protein in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States CD30 (TNFRSF8) Protein Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States CD30 (TNFRSF8) Protein Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of CD30 (TNFRSF8) Protein in China, Company Headquarters and Production Place (Province, Country)
Table 38. China CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China CD30 (TNFRSF8) Protein Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China CD30 (TNFRSF8) Protein Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of CD30 (TNFRSF8) Protein in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World CD30 (TNFRSF8) Protein Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World CD30 (TNFRSF8) Protein Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World CD30 (TNFRSF8) Protein Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World CD30 (TNFRSF8) Protein Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World CD30 (TNFRSF8) Protein Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World CD30 (TNFRSF8) Protein Production by Type (2017-2022) & (K Units)
Table 49. World CD30 (TNFRSF8) Protein Production by Type (2023-2028) & (K Units)
Table 50. World CD30 (TNFRSF8) Protein Production Value by Type (2017-2022) & (USD Million)
Table 51. World CD30 (TNFRSF8) Protein Production Value by Type (2023-2028) & (USD Million)
Table 52. World CD30 (TNFRSF8) Protein Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World CD30 (TNFRSF8) Protein Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World CD30 (TNFRSF8) Protein Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World CD30 (TNFRSF8) Protein Production by Application (2017-2022) & (K Units)
Table 56. World CD30 (TNFRSF8) Protein Production by Application (2023-2028) & (K Units)
Table 57. World CD30 (TNFRSF8) Protein Production Value by Application (2017-2022) & (USD Million)
Table 58. World CD30 (TNFRSF8) Protein Production Value by Application (2023-2028) & (USD Million)
Table 59. World CD30 (TNFRSF8) Protein Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World CD30 (TNFRSF8) Protein Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Sino Biological, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Sino Biological, Inc. Major Business
Table 63. Sino Biological, Inc. CD30 (TNFRSF8) Protein Product and Services
Table 64. Sino Biological, Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Sino Biological, Inc. Recent Developments/Updates
Table 66. Sino Biological, Inc. Competitive Strengths & Weaknesses
Table 67. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 68. Bio-Techne Major Business
Table 69. Bio-Techne CD30 (TNFRSF8) Protein Product and Services
Table 70. Bio-Techne CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Bio-Techne Recent Developments/Updates
Table 72. Bio-Techne Competitive Strengths & Weaknesses
Table 73. Elabscience Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Elabscience Biotechnology Inc. Major Business
Table 75. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Product and Services
Table 76. Elabscience Biotechnology Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Elabscience Biotechnology Inc. Recent Developments/Updates
Table 78. Elabscience Biotechnology Inc. Competitive Strengths & Weaknesses
Table 79. Abbexa Basic Information, Manufacturing Base and Competitors
Table 80. Abbexa Major Business
Table 81. Abbexa CD30 (TNFRSF8) Protein Product and Services
Table 82. Abbexa CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Abbexa Recent Developments/Updates
Table 84. Abbexa Competitive Strengths & Weaknesses
Table 85. MyBiosource, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. MyBiosource, Inc. Major Business
Table 87. MyBiosource, Inc. CD30 (TNFRSF8) Protein Product and Services
Table 88. MyBiosource, Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. MyBiosource, Inc. Recent Developments/Updates
Table 90. MyBiosource, Inc. Competitive Strengths & Weaknesses
Table 91. OriGene Technologies, Inc. Basic Information, Manufacturing Base and Competitors
Table 92. OriGene Technologies, Inc. Major Business
Table 93. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Product and Services
Table 94. OriGene Technologies, Inc. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. OriGene Technologies, Inc. Recent Developments/Updates
Table 96. OriGene Technologies, Inc. Competitive Strengths & Weaknesses
Table 97. Prospec-Tany Technogene Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Prospec-Tany Technogene Ltd. Major Business
Table 99. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Product and Services
Table 100. Prospec-Tany Technogene Ltd. CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Prospec-Tany Technogene Ltd. Recent Developments/Updates
Table 102. Prospec-Tany Technogene Ltd. Competitive Strengths & Weaknesses
Table 103. KACTUS Basic Information, Manufacturing Base and Competitors
Table 104. KACTUS Major Business
Table 105. KACTUS CD30 (TNFRSF8) Protein Product and Services
Table 106. KACTUS CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. KACTUS Recent Developments/Updates
Table 108. KACTUS Competitive Strengths & Weaknesses
Table 109. G&P Biosciences Basic Information, Manufacturing Base and Competitors
Table 110. G&P Biosciences Major Business
Table 111. G&P Biosciences CD30 (TNFRSF8) Protein Product and Services
Table 112. G&P Biosciences CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. G&P Biosciences Recent Developments/Updates
Table 114. G&P Biosciences Competitive Strengths & Weaknesses
Table 115. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 116. ACROBiosystems Major Business
Table 117. ACROBiosystems CD30 (TNFRSF8) Protein Product and Services
Table 118. ACROBiosystems CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. ACROBiosystems Recent Developments/Updates
Table 120. ACROBiosystems Competitive Strengths & Weaknesses
Table 121. Assay Genie Basic Information, Manufacturing Base and Competitors
Table 122. Assay Genie Major Business
Table 123. Assay Genie CD30 (TNFRSF8) Protein Product and Services
Table 124. Assay Genie CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Assay Genie Recent Developments/Updates
Table 126. ZellBio GmbH Basic Information, Manufacturing Base and Competitors
Table 127. ZellBio GmbH Major Business
Table 128. ZellBio GmbH CD30 (TNFRSF8) Protein Product and Services
Table 129. ZellBio GmbH CD30 (TNFRSF8) Protein Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 130. CD30 (TNFRSF8) Protein Raw Material
Table 131. Key Manufacturers of CD30 (TNFRSF8) Protein Raw Materials
Table 132. CD30 (TNFRSF8) Protein Typical Distributors
Table 133. CD30 (TNFRSF8) Protein Typical Customers
LIST OF FIGURES
Figure 1. CD30 (TNFRSF8) Protein Picture
Figure 2. World CD30 (TNFRSF8) Protein Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CD30 (TNFRSF8) Protein Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 5. World CD30 (TNFRSF8) Protein Average Price (2017-2028) & (US$/Unit)
Figure 6. World CD30 (TNFRSF8) Protein Production Value Market Share by Region (2017-2028)
Figure 7. World CD30 (TNFRSF8) Protein Production Market Share by Region (2017-2028)
Figure 8. North America CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 9. Europe CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 10. China CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 11. Japan CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 12. CD30 (TNFRSF8) Protein Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD30 (TNFRSF8) Protein Demand (2017-2028) & (K Units)
Figure 15. World CD30 (TNFRSF8) Protein Consumption Market Share by Region (2017-2028)
Figure 16. United States CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 17. China CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 18. Europe CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 19. Japan CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 20. South Korea CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 21. ASEAN CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 22. India CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of CD30 (TNFRSF8) Protein by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD30 (TNFRSF8) Protein Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD30 (TNFRSF8) Protein Markets in 2021
Figure 26. United States VS China: CD30 (TNFRSF8) Protein Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: CD30 (TNFRSF8) Protein Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: CD30 (TNFRSF8) Protein Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of CD30 (TNFRSF8) Protein in United States
Figure 30. Key Producers and Market Share of CD30 (TNFRSF8) Protein in China
Figure 31. Key Producers and Market Share of CD30 (TNFRSF8) Protein in Rest of World
Figure 32. World CD30 (TNFRSF8) Protein Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World CD30 (TNFRSF8) Protein Production Value Market Share by Type in 2021
Figure 34. Purity : Greater Than 85%
Figure 35. Purity : Greater Than 90%
Figure 36. Purity : Greater Than 95%
Figure 37. Purity : Greater Than 97%
Figure 38. Other
Figure 39. World CD30 (TNFRSF8) Protein Production Market Share by Type (2017-2028)
Figure 40. World CD30 (TNFRSF8) Protein Production Value Market Share by Type (2017-2028)
Figure 41. World CD30 (TNFRSF8) Protein Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World CD30 (TNFRSF8) Protein Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World CD30 (TNFRSF8) Protein Production Value Market Share by Application in 2021
Figure 44. SDS-PAGE
Figure 45. ELISA
Figure 46. Other
Figure 47. World CD30 (TNFRSF8) Protein Production Market Share by Application (2017-2028)
Figure 48. World CD30 (TNFRSF8) Protein Production Value Market Share by Application (2017-2028)
Figure 49. World CD30 (TNFRSF8) Protein Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of CD30 (TNFRSF8) Protein in 2021
Figure 51. Manufacturing Process Analysis of CD30 (TNFRSF8) Protein
Figure 52. CD30 (TNFRSF8) Protein Industrial Chain
Figure 53. Distribution Channel Breakdown for CD30 (TNFRSF8) Protein Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. CD30 (TNFRSF8) Protein Picture
Figure 2. World CD30 (TNFRSF8) Protein Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World CD30 (TNFRSF8) Protein Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 5. World CD30 (TNFRSF8) Protein Average Price (2017-2028) & (US$/Unit)
Figure 6. World CD30 (TNFRSF8) Protein Production Value Market Share by Region (2017-2028)
Figure 7. World CD30 (TNFRSF8) Protein Production Market Share by Region (2017-2028)
Figure 8. North America CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 9. Europe CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 10. China CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 11. Japan CD30 (TNFRSF8) Protein Production (2017-2028) & (K Units)
Figure 12. CD30 (TNFRSF8) Protein Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World CD30 (TNFRSF8) Protein Demand (2017-2028) & (K Units)
Figure 15. World CD30 (TNFRSF8) Protein Consumption Market Share by Region (2017-2028)
Figure 16. United States CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 17. China CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 18. Europe CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 19. Japan CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 20. South Korea CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 21. ASEAN CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 22. India CD30 (TNFRSF8) Protein Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of CD30 (TNFRSF8) Protein by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for CD30 (TNFRSF8) Protein Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for CD30 (TNFRSF8) Protein Markets in 2021
Figure 26. United States VS China: CD30 (TNFRSF8) Protein Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: CD30 (TNFRSF8) Protein Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: CD30 (TNFRSF8) Protein Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of CD30 (TNFRSF8) Protein in United States
Figure 30. Key Producers and Market Share of CD30 (TNFRSF8) Protein in China
Figure 31. Key Producers and Market Share of CD30 (TNFRSF8) Protein in Rest of World
Figure 32. World CD30 (TNFRSF8) Protein Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World CD30 (TNFRSF8) Protein Production Value Market Share by Type in 2021
Figure 34. Purity : Greater Than 85%
Figure 35. Purity : Greater Than 90%
Figure 36. Purity : Greater Than 95%
Figure 37. Purity : Greater Than 97%
Figure 38. Other
Figure 39. World CD30 (TNFRSF8) Protein Production Market Share by Type (2017-2028)
Figure 40. World CD30 (TNFRSF8) Protein Production Value Market Share by Type (2017-2028)
Figure 41. World CD30 (TNFRSF8) Protein Average Price by Type (2017-2028) & (US$/Unit)
Figure 42. World CD30 (TNFRSF8) Protein Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 43. World CD30 (TNFRSF8) Protein Production Value Market Share by Application in 2021
Figure 44. SDS-PAGE
Figure 45. ELISA
Figure 46. Other
Figure 47. World CD30 (TNFRSF8) Protein Production Market Share by Application (2017-2028)
Figure 48. World CD30 (TNFRSF8) Protein Production Value Market Share by Application (2017-2028)
Figure 49. World CD30 (TNFRSF8) Protein Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of CD30 (TNFRSF8) Protein in 2021
Figure 51. Manufacturing Process Analysis of CD30 (TNFRSF8) Protein
Figure 52. CD30 (TNFRSF8) Protein Industrial Chain
Figure 53. Distribution Channel Breakdown for CD30 (TNFRSF8) Protein Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
